Free Trial

Ironwood Pharmaceuticals (IRWD) Earnings Date, Estimates & Call Transcripts

Ironwood Pharmaceuticals logo
$3.64 +0.11 (+3.12%)
(As of 10:50 AM ET)

Ironwood Pharmaceuticals Latest Earnings Summary

Actual EPS
(Nov. 7)
$0.02 Missed By -$0.07
Consensus EPS
(Nov. 7)
$0.09

Ironwood Pharmaceuticals posted Q3 2024 earnings on November 7, 2024, reporting an EPS of $0.02, which missed the consensus estimate of $0.09 by $0.07. Quarterly revenue fell 19.4% year-over-year to $91.60 million, above analysts' expectations of $91.22 million. With a trailing EPS of -$0.03, Ironwood Pharmaceuticals' earnings are expected to grow 162.50% next year, from $0.08 to $0.21 per share.

Get Ironwood Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Ironwood Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

IRWD Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

IRWD Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ironwood Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242$0.14$0.18$0.16
Q2 20242$0.14$0.17$0.16
Q3 20243$0.03$0.16$0.11
Q4 20243$0.08$0.17$0.12
FY 202410$0.39$0.68$0.55
Q1 20252$0.03$0.03$0.03
Q2 20252$0.03$0.05$0.04
Q3 20252$0.05$0.06$0.06
Q4 20252$0.04$0.05$0.05
FY 20258$0.15$0.19$0.17
Q1 20261$0.08$0.08$0.08
Q2 20261$0.09$0.09$0.09
Q3 20261$0.13$0.13$0.13

Ironwood Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/7/2024Q3 2024$0.09$0.02 -$0.07$0.02$91.22M$91.60M
5/9/2024Q1 2024$0.18-$0.02 -$0.20-$0.01$105.75M$74.90M
11/9/2023Q3 2023$0.17$0.12 -$0.05$0.15$112.90M$113.74M
8/8/2023Q2 2023$0.25$0.31+$0.06$7.46$103.46M$107.38M
5/4/2023Q1 2023$0.24$0.25+$0.01$0.25$100.60M$104.06M
2/16/2023Q4 2022$0.28$0.27 -$0.01$0.27$108.23M$107.20M

Ironwood Pharmaceuticals Earnings - Frequently Asked Questions

Ironwood Pharmaceuticals (NASDAQ:IRWD) last announced its quarterly earning data on Thursday, November 7, 2024. Learn more on IRWD's earnings history.

Ironwood Pharmaceuticals issued an update on its FY 2024 earnings guidance on Thursday, November, 7th. The company issued revenue guidance of $350.0 million-$375.0 million, compared to the consensus revenue estimate of $357.2 million.

In the previous quarter, Ironwood Pharmaceuticals (NASDAQ:IRWD) missed the analysts' consensus estimate of $0.09 by $0.07 with a reported earnings per share (EPS) of $0.02. Learn more on analysts' earnings estimate vs. IRWD's actual earnings.

The conference call for Ironwood Pharmaceuticals's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Ironwood Pharmaceuticals's latest earnings report can be read online.
Read Transcript

Ironwood Pharmaceuticals (NASDAQ:IRWD) has a recorded annual revenue of $378.42 million.

Ironwood Pharmaceuticals (NASDAQ:IRWD) has a recorded net income of -$1.00 billion. IRWD has generated -$0.03 earnings per share over the last four quarters.

Ironwood Pharmaceuticals's earnings are expected to grow from $0.08 per share to $0.21 per share in the next year, which is a 162.50% increase.

More Earnings Resources from MarketBeat



This page (NASDAQ:IRWD) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners